Psychedelic drug developer Lykos could get lifeline from former Tesla board member

Psychedelic drug developer Lykos could get lifeline from former Tesla board member

Former Tesla board member Antonio Gracias offers to rescue Lykos Therapeutics with $100M deal to save its psychedelic drug for PTSD. Read more here.

Psychedelic Alpha Post On Linked In Says..."Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing"

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing This latest twist in the Lykos Therapeutics saga threatens a major overhaul of the company’s strategy and direction, with Musk ally and billionaire investor Antonio Gracias appearing to want to take the company back toward its nonprofit drug development roots and a more Doblinite […]

Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing - Psychedelic Alpha

Billionaire investor Antonio Gracias has launched a bid to take control of MDMA drug developer Lykos Therapeutics via $100M of funding and a closer alliance to its nonprofit progenitor, MAPS. Gracias heads up Valor Equity Partners, an investment firm with more than $15 billion in assets under management. It accumulated that pile of cash in large part through early bets on companies… Source

Elon Musk ally leads attempt to seize control of psychedelic biotech Lykos – Sky News: The Latest News from the World

Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest — delivered directly to your inbox. An Elon Musk ally is seeking to seize control of psychedelic drugmaker Lykos Therapeutics, offering it a financial lifeline for its bid to garner US approval to use the party drug ecstasy as a mental […]